This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Friday, June 28, 2013
Mediterranean diet improved hepatic steatosis, insulin sensitivity in patients with NAFLD
Mediterranean diet improved hepatic steatosis, insulin sensitivity in patients with NAFLD
Ryan MC. J Hepatol. 2013;59:138-143.
June 28, 2013
Patients with nonalcoholic fatty liver disease reduced their liver steatosis and improved their insulin sensitivity by adhering to a 6-week Mediterranean diet without experiencing weight loss in a recent study.
Using a cross-over dietary intervention study, researchers compared the results of 12 participants (six men, six women), all with biopsy-proven nonalcoholic fatty liver disease (NAFLD). All were randomly assigned to both a Mediterranean diet and a low-fat, high-carbohydrate diet (LF/HCD) with a 6-week washout period between diets. The MD was high in monounsaturated fats from olive oil and omega 3 polyunsaturated fatty acids. The LF/HCD was low in saturated and unsaturated fats and included more carbohydrates than the MD...
Full Story »
No comments:
Post a Comment